<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Case-control study</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Case-control study.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/study-types/case-control-study.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Inflammation and iron metabolism dysregulation as hallmarks of COVID-19 severity</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3389-fimmu-2026-1908452-606ef91e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3389-fimmu-2026-1908452-606ef91e/</guid>
    <pubDate>Mon, 24 Aug 2026 00:00:00 GMT</pubDate>
    <description>The findings suggest that inflammatory and iron metabolism biomarkers may help stratify COVID-19 severity and identify mechanisms underlying disease progression, including persistent pathology in severe long COVID-19.</description>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Effectiveness of the TYPHIBEV® (Vi-CRM197 conjugate) vaccine introduction in Nepal: A test-negative, case-control study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106719-705b2901/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106719-705b2901/</guid>
    <pubDate>Wed, 01 Apr 2026 00:00:00 GMT</pubDate>
    <description>The documented high protection rate suggests utility for national immunization programs aiming to reduce severe bacterial enteric disease in endemic regions.</description>
    <category>Typhoid fever</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Treatment</category>
    <category>Surveillance</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>CXCR3 is associated with T-cell-induced heart damage in acute rheumatic fever.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-71094-8-c913ca6c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41467-026-71094-8-c913ca6c/</guid>
    <pubDate>Tue, 31 Mar 2026 00:00:00 GMT</pubDate>
    <description>The findings identify a perturbed T cell compartment in acute rheumatic fever and provide a mechanistic rationale for exploring currently available immune-modulating therapies to treat the disease and prevent progressive cardiac damage.</description>
    <category>Rheumatic fever</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>A Case-Control Study on the Effectiveness of Tick-Borne Encephalitis Vaccination Against Hospitalizations in an Endemic Area in Northeastern Italy.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14020164-205efd10/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14020164-205efd10/</guid>
    <pubDate>Tue, 10 Feb 2026 00:00:00 GMT</pubDate>
    <description>The documentation underscores the value of immunization strategies in reducing severe disease outcomes within affected communities. Regional variations in coverage indicate opportunities for targeted outreach initiatives to improve community protection.</description>
    <category>Tick-borne encephalitis</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Climate and environment</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Impact of the indigenous rotavirus vaccine Rotavac in the Universal Immunization Program in India during 2016–2020</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41591-025-03998-9-b96e01f9/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41591-025-03998-9-b96e01f9/</guid>
    <pubDate>Tue, 07 Oct 2025 00:00:00 GMT</pubDate>
    <description>Findings from the abstract suggest Rotavac provided substantial protection against severe rotavirus disease under programmatic conditions in India, including against non-vaccine strains, and was characterized as performing comparably to internationally licensed vaccines in similar settings.</description>
    <category>Gastroenteritis</category>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Surveillance</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Circulating prothymosin alpha and immunoglobulin G3 in acute rheumatic fever and rheumatic heart disease: A case-control study.</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ahjo-2025-100630-7f7211ab/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ahjo-2025-100630-7f7211ab/</guid>
    <pubDate>Mon, 29 Sep 2025 00:00:00 GMT</pubDate>
    <description>Findings are relevant to the lack of specific diagnostic tests for acute rheumatic fever and rheumatic heart disease in low-resource settings, where these diseases impose the greatest burden.</description>
    <category>Rheumatic fever</category>
    <category>Diagnostics</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Influenza Vaccine Effectiveness Against Symptomatic Influenza in Primary Care: A Test Negative Case Control Study Over Two Influenza Seasons 2022/2023 and 2023/2024 in Ireland</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1111-irv-70023-87fbe51b/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1111-irv-70023-87fbe51b/</guid>
    <pubDate>Mon, 02 Dec 2024 00:00:00 GMT</pubDate>
    <description>Continued emphasis on seasonal immunization remains critical for safeguarding vulnerable demographics and pediatric cohorts. Public health initiatives should persist in highlighting documented protective outcomes to sustain coverage rates among eligible groups.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Surveillance</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Influenza vaccine effectiveness in Ireland during two influenza seasons, 2022/23 and 2023/24</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-eurpub-ckae144-1924-adff930a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-eurpub-ckae144-1924-adff930a/</guid>
    <pubDate>Mon, 28 Oct 2024 00:00:00 GMT</pubDate>
    <description>Sustaining routine immunization initiatives appears capable of reducing outpatient utilization for influenza-related illnesses, with notably stronger protective signals observed when administering live attenuated formulations to school-aged youth.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Surveillance</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Risk factors of diphtheria outbreak in damt district of Al Dhalea Governorate, 2023 -Yemen: a case–control study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-024-09932-7-50219630/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-024-09932-7-50219630/</guid>
    <pubDate>Fri, 27 Sep 2024 00:00:00 GMT</pubDate>
    <description>The findings highlight the need to increase vaccination coverage with diphtheria-containing vaccines through routine immunization and tetanus-diphtheria vaccination for childbearing-age females. Community awareness regarding protective measures during home care of diphtheria cases is recommended. Investigation of vaccination service delivery and gender barriers related to tetanus-diphtheria vaccination is warranted.</description>
    <category>Diphtheria</category>
    <category>Tetanus</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Climate and environment</category>
    <category>Travel medicine</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Risk benefit analysis to evaluate risk of thromboembolic events after mRNA COVID-19 vaccination and COVID-19</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41541-024-00960-7-38d314c4/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41541-024-00960-7-38d314c4/</guid>
    <pubDate>Fri, 13 Sep 2024 00:00:00 GMT</pubDate>
    <description>The findings support vaccination strategies by demonstrating that despite modest increases in post-vaccination thromboembolic risk, the overall effect of mRNA COVID-19 vaccination reduces thromboembolic event burden through prevention of infection-associated events, with greater benefit during high transmission periods.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Vaccine effectiveness</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>A combined cross-sectional analysis and case-control study evaluating tick-borne encephalitis vaccination coverage, disease and vaccine effectiveness in children and adolescents, Switzerland, 2005 to 2022</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-18-2300558-9973be5c/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2024-29-18-2300558-9973be5c/</guid>
    <pubDate>Thu, 02 May 2024 00:00:00 GMT</pubDate>
    <description>The findings support vaccination recommendations by demonstrating that even young children can experience severe TBE and that complete vaccination provides durable protection against neurological disease for at least 10 years.</description>
    <category>Tick-borne encephalitis</category>
    <category>Surveillance</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa2215201-466804dd/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1056-nejmoa2215201-466804dd/</guid>
    <pubDate>Thu, 29 Jun 2023 00:00:00 GMT</pubDate>
    <description>The findings support the usefulness of JYNNEOS vaccination against mpox disease and suggest greater protection with completion of the two-dose series, relevant to U.S. outbreak control among at-risk adults.</description>
    <category>Monkeypox</category>
    <category>Smallpox</category>
    <category>HIV infection</category>
    <category>AIDS</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Outbreak investigation</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Case-control investigation of invasive Salmonella disease in Malawi reveals no evidence of environmental or animal transmission of invasive strains, and supports human to human transmission</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0010982-aa90c595/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0010982-aa90c595/</guid>
    <pubDate>Mon, 12 Dec 2022 00:00:00 GMT</pubDate>
    <description>The study is relevant to understanding invasive Salmonella transmission in a household and One Health context in Malawi. It also highlights the value of household sampling for transmission-oriented epidemiology and the challenge of detecting S. Typhi from the environment.</description>
    <category>Typhoid fever</category>
    <category>Transmission dynamics</category>
    <category>Climate and environment</category>
    <category>One Health</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41467-022-33378-7-3e9beeac/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41467-022-33378-7-3e9beeac/</guid>
    <pubDate>Fri, 30 Sep 2022 00:00:00 GMT</pubDate>
    <description>The findings demonstrate that incidental hospital admissions with Omicron may lead to underestimation of vaccine protection against severe disease, emphasizing the need for precise case definitions in vaccine effectiveness surveillance.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Diagnostics</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41591-021-01446-y-de6639e9/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41591-021-01446-y-de6639e9/</guid>
    <pubDate>Fri, 09 Jul 2021 00:00:00 GMT</pubDate>
    <description>The findings demonstrate high vaccine effectiveness against variants of concern and severe outcomes, supporting vaccination efforts during periods of variant circulation.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Treatment</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Monovalent Rotavirus Vaccine Effectiveness Against Rotavirus Hospitalizations Among Children in Zimbabwe</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciy1096-9c81d32a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-ciy1096-9c81d32a/</guid>
    <pubDate>Sun, 23 Dec 2018 00:00:00 GMT</pubDate>
    <description>The documented protective outcomes reinforce the utility of oral rotavirus immunizations in regions experiencing elevated pediatric mortality. These findings may assist public health authorities in evaluating immunization adoption strategies for comparable epidemiological environments.</description>
    <category>Gastroenteritis</category>
    <category>Vaccination</category>
    <category>Vaccine effectiveness</category>
    <category>Surveillance</category>
    <category>Treatment</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2017-22-44-17-00306-d17fed69/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-2807-1560-7917-es-2017-22-44-17-00306-d17fed69/</guid>
    <pubDate>Thu, 02 Nov 2017 00:00:00 GMT</pubDate>
    <description>These results bolster the rationale for sustaining youth immunization initiatives while underscoring the continued necessity of developing robust protective strategies for elderly populations.</description>
    <category>Influenza</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Diagnostics</category>
    <category>Vaccine effectiveness</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Prisons as Reservoir for Community Transmission of Tuberculosis, Brazil</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-3201-eid2103-140896-a6c0c970/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-3201-eid2103-140896-a6c0c970/</guid>
    <pubDate>Sun, 01 Mar 2015 00:00:00 GMT</pubDate>
    <description>Controlling tuberculosis in prison settings is critical for reducing disease prevalence in the broader community, as prisons may serve as reservoirs for community transmission.</description>
    <category>Tuberculosis</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Treatment</category>
    <category>Climate and environment</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>A food-borne outbreak of gastroenteritis caused by norovirus GII in a university located in Xiamen City, China</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2014-06-022-87a47e0a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-ijid-2014-06-022-87a47e0a/</guid>
    <pubDate>Sat, 01 Nov 2014 00:00:00 GMT</pubDate>
    <description>The report is relevant to foodborne outbreak investigation and transmission dynamics in a university setting. It describes a norovirus-associated outbreak linked to a food source and a possibly infected food handler.</description>
    <category>Gastroenteritis</category>
    <category>Outbreak investigation</category>
    <category>Transmission dynamics</category>
    <category>Climate and environment</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>The Global Enteric Multicenter Study (GEMS): Impetus, Rationale, and Genesis</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1093-cid-cis761-71642628/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1093-cid-cis761-71642628/</guid>
    <pubDate>Tue, 20 Nov 2012 00:00:00 GMT</pubDate>
    <description>The work addresses diarrheal disease, cited as one of the top two causes of young child mortality in the developing world, and aims to inform prioritization of water/sanitation, hygiene, and vaccine strategies.</description>
    <category>Gastroenteritis</category>
    <category>Treatment</category>
    <category>Vaccination</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Case-control study</category>
  </item>
  <item>
    <title>Measles outbreak in Burkina Faso, 2009: A case–control study to determine risk factors and estimate vaccine effectiveness</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2012-05-024-3c82bb18/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2012-05-024-3c82bb18/</guid>
    <pubDate>Sun, 01 Jul 2012 00:00:00 GMT</pubDate>
    <description>The authors emphasize that findings support improved strategies to reduce missed vaccination opportunities and achieve high nationwide measles vaccination coverage to prevent large outbreaks and advance measles mortality reduction.</description>
    <category>Measles</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Vaccine effectiveness</category>
    <category>Surveillance</category>
    <category>Case-control study</category>
  </item>
</channel>
</rss>
